Prot #CPI‐IFE‐008: A Randomized, Double‐Blind, Placebo‐Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients with Idiopathic Pulmonary Fibrosis

Project: Research project

Project Details

StatusActive
Effective start/end date10/3/2310/3/26

Funding

  • Cumberland Pharmaceuticals Inc. (Prot #CPI-IFE-008)